Rwc Asset Management Llp Has Trimmed Merck & Co (MRK) Stake By $2.57 Million; Carl Zeiss Meditec AG (ETR:AFX) Had 5 Analysts Last Week

June 19, 2017 - By Marguerite Chambers

Among 11 analysts covering Carl Zeiss Meditec (ETR:AFX), 5 have Buy rating, 2 Sell and 4 Hold. Therefore 45% are positive. Carl Zeiss Meditec had 46 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Commerzbank on Saturday, December 10 with “Hold”. The rating was upgraded by Landesbank on Thursday, August 18 to “Buy”. The stock has “Buy” rating by DZ-Bank AG on Thursday, August 27. The firm has “Buy” rating by Kepler Cheuvreux given on Monday, December 28. The stock of Carl Zeiss Meditec AG (ETR:AFX) earned “Buy” rating by Landesbank on Tuesday, October 13. The firm has “Buy” rating by DZ-Bank AG given on Saturday, October 3. The rating was maintained by JP Morgan on Friday, October 23 with “Neutral”. The firm earned “Neutral” rating on Saturday, February 11 by Independent Research. The company was upgraded on Thursday, May 12 by Kepler Cheuvreux. On Saturday, December 10 the stock rating was upgraded by Berenberg to “Buy”. See Carl Zeiss Meditec AG (ETR:AFX) latest ratings:

21/02/2017 Broker: Landesbank Rating: Buy New Target: €45.00 Upgrade
11/02/2017 Broker: Kepler Cheuvreux Rating: Buy New Target: €38.00 Upgrade
11/02/2017 Broker: Independent Research Rating: Neutral New Target: €38.00 Maintain
21/12/2016 Broker: Deutsche Bank Rating: Hold New Target: €34.00 Maintain

Rwc Asset Management Llp decreased Merck & Co Inc (MRK) stake by 4.23% reported in 2016Q4 SEC filing. Rwc Asset Management Llp sold 44,252 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Rwc Asset Management Llp holds 1.00M shares with $59.01 million value, down from 1.05 million last quarter. Merck & Co Inc now has $173.68 billion valuation. The stock rose 1.19% or $0.75 reaching $63.72. About 3.78M shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since June 19, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.

Among 17 analysts covering Merck & Co. Inc. (NYSE:MRK), 12 have Buy rating, 1 Sell and 4 Hold. Therefore 71% are positive. Merck & Co. Inc. had 36 analyst reports since August 13, 2015 according to SRatingsIntel. As per Monday, December 19, the company rating was downgraded by Jefferies. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) rating on Thursday, May 25. Jefferies has “Sell” rating and $51 target. Morgan Stanley upgraded the shares of MRK in report on Thursday, January 12 to “Overweight” rating. The rating was upgraded by Berenberg to “Hold” on Thursday, August 27. Societe Generale initiated the shares of MRK in report on Wednesday, April 6 with “Buy” rating. The firm has “Hold” rating given on Wednesday, September 30 by Societe Generale. The rating was upgraded by Guggenheim to “Buy” on Thursday, January 12. The company was maintained on Thursday, July 14 by Jefferies. As per Monday, July 18, the company rating was downgraded by BMO Capital Markets. The firm has “Neutral” rating given on Monday, May 9 by Credit Suisse.

Investors sentiment increased to 1.1 in 2016 Q4. Its up 0.05, from 1.05 in 2016Q3. It improved, as 66 investors sold MRK shares while 603 reduced holdings. 128 funds opened positions while 609 raised stakes. 1.96 billion shares or 0.02% more from 1.96 billion shares in 2016Q3 were reported. Holderness Invests Com holds 1.09% or 20,967 shares in its portfolio. Quest Invest Mgmt Or holds 18,000 shares or 0.14% of its portfolio. Private Gp Incorporated owns 353,908 shares or 1.18% of their US portfolio. Barrington Strategic Wealth Grp Inc Ltd Liability stated it has 0.5% of its portfolio in Merck & Co., Inc. (NYSE:MRK). M Kraus & invested in 8,363 shares. Pekin Singer Strauss Asset Management Il holds 0.39% in Merck & Co., Inc. (NYSE:MRK) or 73,559 shares. Sprucegrove Mngmt Limited invested in 0.56% or 194,000 shares. Moreover, Argyle Inc has 2.35% invested in Merck & Co., Inc. (NYSE:MRK) for 94,010 shares. First Washington, Washington-based fund reported 552 shares. Federated Investors Pa accumulated 11.31 million shares. Tower Bridge Advsrs reported 117,033 shares. Ahl Partners Limited Liability Partnership holds 0.06% or 34,954 shares in its portfolio. Birchview Limited Partnership holds 15,000 shares or 0.54% of its portfolio. Blume Capital Mngmt reported 0.06% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Modera Wealth Limited Liability holds 0.18% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 8,825 shares.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on July, 28. They expect $0.88 earnings per share, down 5.38% or $0.05 from last year’s $0.93 per share. MRK’s profit will be $2.40B for 18.10 P/E if the $0.88 EPS becomes a reality. After $0.88 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Rwc Asset Management Llp increased Lennar Corp (NYSE:LEN) stake by 35,208 shares to 167,174 valued at $7.18M in 2016Q4. It also upped Scotts Miracle Gro Co (NYSE:SMG) stake by 25,878 shares and now owns 131,715 shares. Monsanto Co New (NYSE:MON) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: